PIROLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 4.797
EU - Europa 2.379
AS - Asia 936
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 5
AF - Africa 4
OC - Oceania 3
Totale 8.131
Nazione #
US - Stati Uniti d'America 4.706
DE - Germania 559
IT - Italia 445
SE - Svezia 378
CN - Cina 369
SG - Singapore 347
IE - Irlanda 320
UA - Ucraina 182
RU - Federazione Russa 160
GB - Regno Unito 133
CA - Canada 90
FI - Finlandia 58
HK - Hong Kong 50
FR - Francia 42
TR - Turchia 36
VN - Vietnam 36
IN - India 35
DK - Danimarca 33
BE - Belgio 30
ID - Indonesia 28
JP - Giappone 12
NL - Olanda 11
IR - Iran 9
EU - Europa 7
KR - Corea 6
PL - Polonia 6
CH - Svizzera 5
CZ - Repubblica Ceca 5
AT - Austria 3
AU - Australia 3
BR - Brasile 3
LT - Lituania 3
MY - Malesia 2
RO - Romania 2
SC - Seychelles 2
TH - Thailandia 2
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
MU - Mauritius 1
MX - Messico 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 8.131
Città #
Ann Arbor 1.069
Woodbridge 418
Fairfield 378
Chandler 347
Houston 343
Frankfurt am Main 315
Dublin 310
Singapore 266
Wilmington 247
Ashburn 236
Dearborn 225
Milan 211
Jacksonville 177
Seattle 168
Cambridge 123
New York 114
Santa Clara 88
Princeton 86
Nanjing 64
Göttingen 61
Shanghai 54
Hong Kong 50
Beijing 45
Altamura 37
Lawrence 36
Brussels 30
Lachine 29
Boardman 28
Jakarta 28
Ottawa 28
Shenyang 25
Nanchang 24
Dong Ket 23
Fürstenwalde 21
San Diego 21
Helsinki 20
Munich 20
Andover 19
Fremont 19
Guangzhou 19
Kocaeli 19
Falls Church 17
Hebei 16
Tianjin 15
Toronto 15
Los Angeles 14
Lissone 13
Jiaxing 12
Kunming 12
London 12
Edmonton 11
Jinan 11
Norwalk 11
Pavia 10
Pune 10
Romola 9
Changsha 8
Kiev 8
Nürnberg 8
Redmond 7
Bonndorf 6
Espoo 6
Hefei 6
Lodz 6
Zanjan 6
Dallas 5
Huizen 5
Ningbo 5
Taku 5
Marseille 4
Mountain View 4
Mumbai 4
Paullo 4
Washington 4
Auburn Hills 3
Bari 3
Birmingham 3
Boston 3
Daejeon 3
Kilburn 3
Leawood 3
Meaux 3
Montréal 3
Moscow 3
Motta Di Livenza 3
Olomouc 3
Phoenix 3
Quartu Sant'elena 3
Rome 3
Zhengzhou 3
Acton 2
Bangalore 2
Bangkok 2
Berlin 2
Brno 2
Bryn Mawr 2
Buffalo 2
Chicago 2
Clifton 2
Colle Umberto 2
Totale 6.198
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 406
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 364
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 309
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 304
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 289
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 289
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 280
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 274
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 272
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 266
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 226
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 222
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 208
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 205
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 204
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 204
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 201
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 201
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 197
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 189
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 181
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 176
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 173
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 170
Whole-Exome Sequencing Data - Identifying Somatic Mutations 170
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 167
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 164
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 163
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 161
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 158
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 154
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 152
Identification of Novel Point Mutations in Splicing Sites by the Integration of Exome and RNA Sequencing Data in Myeloproliferative Diseases 147
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 146
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 142
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 138
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 127
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 119
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 114
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 110
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 93
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 90
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 84
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 74
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 39
Totale 8.522
Categoria #
all - tutte 26.076
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.076


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020749 0 0 0 0 0 0 254 102 136 127 94 36
2020/20211.392 70 71 149 166 118 116 145 130 106 134 82 105
2021/2022637 47 70 75 52 32 61 36 33 33 64 51 83
2022/20231.330 143 400 129 128 104 196 12 76 79 17 28 18
2023/2024886 27 35 34 53 110 270 176 12 49 25 8 87
2024/2025788 135 166 120 97 194 74 2 0 0 0 0 0
Totale 8.522